Unknown

Dataset Information

0

Octahedron Iron Oxide Nanocrystals Prohibited Clostridium difficile Spore Germination and Attenuated Local and Systemic Inflammation.


ABSTRACT: Clinical management of Clostridium difficile infection is still far from satisfactory as bacterial spores are resistant to many chemical agents and physical treatments. Certain types of nanoparticles have been demonstrated to exhibit anti-microbial efficacy even in multi-drug resistance bacteria. However, most of these studies failed to show biocompatibility to the mammalian host cells and no study has revealed in vivo efficacy in C. difficile infection animal models. The spores treated with 500?µg/mL Fe3-?O4 nanoparticles for 20?minutes, 64% of the spores were inhibited from transforming into vegetative cells, which was close to the results of the sodium hypochlorite-treated positive control. By cryo-electron micro-tomography, we demonstrated that Fe3-?O4 nanoparticles bind on spore surfaces and reduce the dipicolinic acid (DPA) released by the spores. In a C. difficile infection animal model, the inflammatory level triple decreased in mice with colonic C. difficile spores treated with Fe3-?O4 nanoparticles. Histopathological analysis showed a decreased intense neutrophil accumulation in the colon tissue of the Fe3-?O4 nanoparticle-treated mice. Fe3-?O4 nanoparticles, which had no influence on gut microbiota and apparent side effects in vivo, were efficacious inhibitors of C. difficile spore germination by attacking its surface and might become clinically feasible for prophylaxis and therapy.

SUBMITTER: Lee WT 

PROVIDER: S-EPMC5558001 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Octahedron Iron Oxide Nanocrystals Prohibited Clostridium difficile Spore Germination and Attenuated Local and Systemic Inflammation.

Lee Wei-Ting WT   Wu Ya-Na YN   Chen Yi-Hsuan YH   Wu Shang-Rung SR   Shih Tsai-Miao TM   Li Tsung-Ju TJ   Yang Li-Xing LX   Yeh Chen-Sheng CS   Tsai Pei-Jane PJ   Shieh Dar-Bin DB  

Scientific reports 20170815 1


Clinical management of Clostridium difficile infection is still far from satisfactory as bacterial spores are resistant to many chemical agents and physical treatments. Certain types of nanoparticles have been demonstrated to exhibit anti-microbial efficacy even in multi-drug resistance bacteria. However, most of these studies failed to show biocompatibility to the mammalian host cells and no study has revealed in vivo efficacy in C. difficile infection animal models. The spores treated with 500  ...[more]

Similar Datasets

| S-EPMC6060349 | biostudies-literature
| S-EPMC6697597 | biostudies-literature
| S-EPMC4524186 | biostudies-literature
| S-EPMC4732931 | biostudies-literature
| S-EPMC4619724 | biostudies-literature
| S-EPMC5648855 | biostudies-literature
| S-EPMC9295549 | biostudies-literature
| S-EPMC5877410 | biostudies-literature
| S-EPMC3917228 | biostudies-literature
| S-EPMC5481577 | biostudies-literature